What should I know first?
Guanfacine is an agonist at alpha-2A adrenergic receptors. An agonist activates a receptor. This action differs from blocking a messenger’s return through a transporterTransporterA protein that moves a substance across a cell membrane. Some transporters help remove released chemical messengers from the space around nerve cells.Read the full definition of Transporter.
The UK Intuniv prolonged-release information supports this lesson. Its product-specific ADHD licence and safety rules must be checked separately; the US use on its own or alongside a stimulant is not automatically a UK licensing statement.
This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.
How Brain Cells Communicate
Noradrenaline, also called norepinephrine, can act at several adrenergic receptor types. Alpha-2A names one subtype. A receptor response can change internal signalling rather than directly moving a messenger across the membraneCell membraneThe thin boundary of a cell. It separates the inside from the surroundings and contains proteins that control transport and signaling.Read the full definition of Cell membrane.
- Norepinephrine
A messenger can change signaling through its receptor.
- Alpha-2A receptor
This receptor symbol identifies a function, not a molecular structure.
- Cell response
The arrow represents a signaling response, not movement through a pore.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
About this illustration
A messenger acts at a receptor and changes cell signalling. Alpha-2A is one of several adrenergic receptor subtypes.
How the Medication Changes Signalling
Guanfacine activates central alpha-2A receptors. It is not a central nervous system stimulant. Receptor activation affects cell signalling, but it does not mean that all noradrenaline activity simply increases.
The label also describes effects on sympathetic nerve signals, heart rate and blood pressure. These help explain why the mechanism lesson cannot replace the product’s precautions.
A Closer Look at the Molecular Level
Known action: alpha-2A receptor agonism is established in product pharmacology. The icon does not show a receptor’s atomic structure or a measured activation level.
Clinical uncertainty: the mechanism of guanfacine’s benefit in ADHD is not known. A receptor interaction does not diagnose a signalling deficit or predict attention in a person.
Sources and References
- Intuniv 1 mg prolonged-release tablets: UK SmPC
Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.
Scope: United Kingdom.
- What Is a Neurotransmitter?
Scope: International scientific education; not UK regulatory evidence.
Article Information
- Edition
- United Kingdom
- Content updated
- 2026-10-17
- Sources checked
- Listed with each reference above; retained dates for shared scientific content.
- Publication status
- Published
- Scope
- How this medicine works, with UK product information.
Source and coverage limits
- A mechanism lesson is not a complete medicine profile, dosing schedule or individual treatment recommendation.
- Original qualitative SVG diagrams explain direction and target type; they do not measure biological rates, binding geometry or clinical response.

